Cargando…

Comparison of Brain Natriuretic Peptide Levels to Simultaneously Obtained Right Heart Hemodynamics in Stable Outpatients with Pulmonary Arterial Hypertension

Pulmonary arterial hypertension (PAH) is a progressive disease that requires validated biomarkers of disease severity. While PAH is defined hemodynamically by right heart catheterization (RHC), brain natriuretic peptide (BNP) is recommended by guidelines to assess disease status. Retrospectively col...

Descripción completa

Detalles Bibliográficos
Autores principales:	Helgeson, Scott A., Imam, J. Saadi, Moss, John E., Hodge, David O., Burger, Charles D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023321/ https://www.ncbi.nlm.nih.gov/pubmed/29723983 http://dx.doi.org/10.3390/diseases6020033

Ejemplares similares

The Molar Ratio of N-terminal pro-B-type Natriuretic Peptide/B-type Natriuretic Peptide for Heart Failure-related Events in Stable Outpatients with Cardiovascular Risk Factors
por: Suzuki, Satoru, et al.
Publicado: (2018)

Human genetics, natriuretic peptides and hypertension
por: Newton-Cheh, Christopher
Publicado: (2011)

Manipulating the natriuretic peptide system for the treatment of pulmonary hypertension
por: Baliga, Reshma S, et al.
Publicado: (2009)

Cardiac Natriuretic Peptides, Hypertension and Cardiovascular Risk
por: Sarzani, Riccardo, et al.
Publicado: (2017)

Facemasks and Walk Distance in Pulmonary Arterial Hypertension Patients
por: Helgeson, Scott A., et al.
Publicado: (2021)

Non-invasive evaluation of hemodynamics in pulmonary hypertension by a Septal angle measured by computed tomography pulmonary angiography: Comparison with right-heart catheterization and association with N-terminal pro-B-type natriuretic peptide
por: TANG, QIANG, et al.
Publicado: (2013)

Endothelial actions of atrial natriuretic peptide prevent pulmonary hypertension in mice
por: Werner, Franziska, et al.
Publicado: (2016)

The Correlations of Human Atrial Natriuretic Peptide on Cardiac Function and Hemodynamics in Pediatric Septic Shock
por: Setyaningtyas, Arina, et al.
Publicado: (2022)

Brain natriuretic peptide in pulmonary arterial hypertension: biomarker and potential therapeutic agent
por: Casserly, Brian, et al.
Publicado: (2009)

Correction to: Endothelial actions of atrial natriuretic peptide prevent pulmonary hypertension in mice
por: Werner, Franziska, et al.
Publicado: (2022)

The Utility of Brain Natriuretic Peptide in Patients Undergoing an Initial Evaluation for Pulmonary Hypertension
por: Rao, Sanjana, et al.
Publicado: (2022)

The degree of natriuretic peptide system activation in stable and high risk CHF characterized by increased cystatin C is not reflected in cGMP activation
por: Schirger, John A, et al.
Publicado: (2009)

Remote 6-minute-Walk Testing in Patients with Pulmonary Hypertension: Further Validation Needed?
por: Helgeson, Scott A., et al.
Publicado: (2022)

Comparing Diagnosis and Treatment of Pulmonary Hypertension Patients at a Pulmonary Hypertension Center versus Community Centers
por: Saunders, Hollie, et al.
Publicado: (2022)

Plasma atrial natriuretic peptide and N-terminal pro B-type natriuretic peptide concentrations in dogs with right-sided congestive heart failure
por: KANNO, Nobuyuki, et al.
Publicado: (2015)

Heads and Tails of Natriuretic Peptides: Neuroprotective Role of Brain Natriuretic Peptide
por: Fernández‐Susavila, Héctor, et al.
Publicado: (2017)

Monitoring of Hemodynamics With Right Heart Catheterization in Children With Pulmonary Arterial Hypertension
por: Grynblat, Julien, et al.
Publicado: (2023)

Psychosocial and Financial Burden of Therapy in USA Patients with Pulmonary Arterial Hypertension
por: Helgeson, Scott A., et al.
Publicado: (2020)

The association of N-terminal pro-brain-type natriuretic peptide with hemodynamics and functional capacity in therapy-naive precapillary pulmonary hypertension: results from a cohort study
por: Berghaus, T. M., et al.
Publicado: (2017)

Natriuretic Peptide and Clinical Evaluation in the Diagnosis of Heart Failure Hemodynamic Profile: Comparison with Tissue Doppler Echocardiography
por: de Almeida Junior, Gustavo Luiz Gouvêa, et al.
Publicado: (2018)

Augmented expression of cardiac atrial natriuretic peptide system in hypertensive rats.
por: An, M. R., et al.
Publicado: (1999)

Associations of plasma atrial natriuretic peptide and electrolyte levels with essential hypertension
por: HU, GUANGMEI, et al.
Publicado: (2013)

Taipan Natriuretic Peptides Are Potent and Selective Agonists for the Natriuretic Peptide Receptor A
por: Vink, Simone, et al.
Publicado: (2023)

Utility of point-of-care testing of natriuretic peptides (brain natriuretic peptide and n-terminal pro-brain natriuretic peptide) in the emergency department
por: Nayer, Jamshed, et al.
Publicado: (2014)

Does Right Ventricular Dysfunction Predict Mortality in Hemodynamically Stable Patients With Acute Pulmonary Embolism?
por: Chaudhary, Ahmad, et al.
Publicado: (2017)

Clinical study of right ventricular longitudinal strain for assessing right ventricular dysfunction and hemodynamics in pulmonary hypertension
por: Li, Yidan, et al.
Publicado: (2016)

Evaluation of the hemodynamics and right ventricular function in pulmonary hypertension by echocardiography compared with right-sided heart catheterization
por: Li, Yidan, et al.
Publicado: (2017)

Associates of an Elevated Natriuretic Peptide Level in Stable Heart Failure Patients: Implications for Targeted Management
por: Jan, Aftab, et al.
Publicado: (2013)

The Prognostic Value of Natriuretic Peptides in Stable Patients with Suspected Acute Myocarditis: A Retrospective Study
por: Moady, Gassan, et al.
Publicado: (2022)

Intrinsic defence capacity and therapeutic potential of natriuretic peptides in pulmonary hypertension associated with lung fibrosis
por: Baliga, R S, et al.
Publicado: (2014)

Constitutively active form of natriuretic peptide receptor 2 ameliorates experimental pulmonary arterial hypertension
por: Nawa, Nobutoshi, et al.
Publicado: (2016)

Usefulness of Serum Brain Natriuretic Peptide Level for Screening Hemodynamically Significant Patent Ductus Arteriosus in Preterm Neonates
por: Jameii Khosroshahi, Ahmad, et al.
Publicado: (2014)

N-terminal pro-brain natriuretic peptide measurements in hemodynamically significant patent ductus arteriosus in preterm infants
por: Alenazi, Shehab Ahmed
Publicado: (2016)

Echocardiographic markers of pulmonary hemodynamics and right ventricular hypertrophy in rat models of pulmonary hypertension
por: Spyropoulos, Fotios, et al.
Publicado: (2020)

Effects of right ventricular septal versus apical pacing on plasma natriuretic peptide levels
por: Nikoo, M. H., et al.
Publicado: (2011)

The correlation between serum level of brain natriuretic peptide and amount of left to right shunt
por: Jamei Khosroshahi, Ahmad, et al.
Publicado: (2019)

Twelve-Year Survival in a Patient With Systemic Sclerosis–Associated Pulmonary Arterial Hypertension on Nifedipine Monotherapy
por: Helgeson, Scott A., et al.
Publicado: (2019)

Natriuretic Peptides, Cognitive Impairment and Dementia: An Intriguing Pathogenic Link with Implications in Hypertension
por: Gallo, Giovanna, et al.
Publicado: (2020)

A novel natriuretic peptide
por: Höfeld, Hanna, et al.
Publicado: (2011)

Natriuretic peptides and fat metabolism
por: Collins, Sheila
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_mkpg5h3qc99n8k06f4kg8cq89c